CRF1 AND ACTH INHIBITORS ARE A PROMISING APPROACH TO TREAT OBESITY AND LEPTIN AND INSULIN RESISTANCE

Descargar Publicación
Enfermedades cardiovasculares causaron 1 de cada 3 muertes en 2023 Dietary supplement considerations during glucagon-like Peptide-1 receptor agonist treatment: A narrative review